| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |